Back to Search
Start Over
In-Human Implantation of a Novel Biologic Valved Conduit for Aortic Root Replacement.
- Source :
-
The Annals of thoracic surgery [Ann Thorac Surg] 2022 Jan; Vol. 113 (1), pp. e21-e24. Date of Electronic Publication: 2021 Apr 09. - Publication Year :
- 2022
-
Abstract
- Aortic root replacement is a complex procedure. Recently, the KONECT RESILIA aortic valved conduit (Edwards Lifesciences, Irvine, CA), the first prefabricated biologic valved conduit available in the United States, was approved for use. Here, we report a series of 3 patients representing implantation of the novel Konect AVC. The conduit was implanted in both supraannular and intraannular positions, and the unique design of the sewing ring offers several advantages. The Konect AVC streamlines the process of root replacement and may represent an improvement in terms of ease of implantation and durability.<br /> (Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1552-6259
- Volume :
- 113
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- The Annals of thoracic surgery
- Publication Type :
- Academic Journal
- Accession number :
- 33839132
- Full Text :
- https://doi.org/10.1016/j.athoracsur.2021.03.087